Wednesday, January 20, 2016

British Journal of Cancer - Table of Contents alert Volume 114 Issue 2

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 114, Issue 2 (125-236)
Published online 19 January 2016

In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Minireview

Top

Gene–environment interaction and risk of breast cancer

Anja Rudolph, Jenny Chang-Claude and Marjanka K Schmidt

Br J Cancer 2016 114: 125-133; advance online publication, January 12, 2016; 10.1038/bjc.2015.439

Abstract | Full Text

Clinical Studies

Top

Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer

Duncan C Gilbert, Eva Serup-Hansen, Dorte Linnemann, Estrid Høgdall, Charles Bailey, Jeff Summers, Hanne Havsteen and Gareth J Thomas

Br J Cancer 2016 114: 134-137; advance online publication, January 5, 2016; 10.1038/bjc.2015.448

Abstract | Full Text

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer

Yilin Li, Jifang Gong, Qiyue Zhang, Zhihao Lu, Jing Gao, Yanyan Li, Yanshuo Cao and Lin Shen

Br J Cancer 2016 114: 138-145; 10.1038/bjc.2015.417

Abstract | Full Text

Has the survival of patients with glioblastoma changed over the years?

R M deSouza, H Shaweis, C Han, V Sivasubramiam, L Brazil, R Beaney, G Sadler, S Al-Sarraj, T Hampton, J Logan, V Hurwitz, R Bhangoo, R Gullan and K Ashkan

Br J Cancer 2016 114: 146-150; advance online publication, December 15, 2015; 10.1038/bjc.2015.421

Abstract | Full Text

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours

Matthew J Murray, Emma Bell, Katie L Raby, Martin A Rijlaarsdam, Ad J M Gillis, Leendert H J Looijenga, Helen Brown, Benoit Destenaves, James C Nicholson and Nicholas Coleman

Br J Cancer 2016 114: 151-162; advance online publication, December 15, 2015; 10.1038/bjc.2015.429

Abstract | Full Text

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Christoph Zielinski, Istvan Lang, Semir Beslija, Zsuzsanna Kahan, Moshe J Inbar, Salomon M Stemmer, Rodica Anghel, Damir Vrbanec, Diethelm Messinger and Thomas Brodowicz

Br J Cancer 2016 114: 163-170; advance online publication, December 10, 2015; 10.1038/bjc.2015.419

Abstract | Full Text

A randomised trial of the effect of postal reminders on attendance for breast screening

Prue C Allgood, Anthony J Maxwell, Sue Hudson, Judith Offman, Gillian Hutchison, Cathryn Beattie, Raquel Tuano-Donnelly, Anthony Threlfall, Tina Summersgill, Lesley Bellis, Collette Robinson, Samantha Heaton, Julietta Patnick and Stephen W Duffy

Br J Cancer 2016 114: 171-176; 10.1038/bjc.2015.451

Abstract | Full Text

Translational Therapeutics

Top

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

Marie-Emmanuelle Legrier, Ivan Bièche, Julie Gaston, Arnaud Beurdeley, Vanessa Yvonnet, Olivier Déas, Aurélie Thuleau, Sophie Château-Joubert, Jean-Luc Servely, Sophie Vacher, Myriam Lassalle, Stéphane Depil, Gordon C Tucker, Jean-Jacques Fontaine, Marie-France Poupon, Sergio Roman-Roman, Jean-Gabriel Judde, Didier Decaudin, Stefano Cairo and Elisabetta Marangoni

Br J Cancer 2016 114: 177-187; advance online publication, December 22, 2015; 10.1038/bjc.2015.398

Abstract | Full Text

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

Z Zakaria, A Tivnan, L Flanagan, D W Murray, M Salvucci, B W Stringer, B W Day, A W Boyd, D Kögel, M Rehm, D F O’Brien, A T Byrne and J H M Prehn

Br J Cancer 2016 114: 188-198; advance online publication, December 10, 2015; 10.1038/bjc.2015.420

Abstract | Full Text

Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis

Sun A Kim, Kentaro Inamura, Mai Yamauchi, Reiko Nishihara, Kosuke Mima, Yasutaka Sukawa, Tingting Li, Mika Yasunari, Teppei Morikawa, Kathryn C Fitzgerald, Charles S Fuchs, Kana Wu, Andrew T Chan, Xuehong Zhang, Shuji Ogino and Zhi Rong Qian

Br J Cancer 2016 114: 199-206; advance online publication, January 7, 2016; 10.1038/bjc.2015.347

Abstract | Full Text

Molecular Diagnostics

Top

Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy

Bimal Bhindi, Thomas Hermanns, Yanliang Wei, Julie Yu, Patrick O Richard, Marian S Wettstein, Arnoud Templeton, Kathy Li, Srikala S Sridhar, Michael A S Jewett, Neil E Fleshner, Alexandre R Zlotta and Girish S Kulkarni

Br J Cancer 2016 114: 207-212; advance online publication, December 10, 2015; 10.1038/bjc.2015.432

Abstract | Full Text

E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer

Fabian Trillsch, Sascha Kuerti, Christine Eulenburg, Eike Burandt, Linn Woelber, Katharina Prieske, Kathrin Eylmann, Leticia Oliveira-Ferrer, Karin Milde-Langosch and Sven Mahner

Br J Cancer 2016 114: 207-212; 10.1038/bjc.2015.436

Abstract | Full Text

Genetics & Genomics

Top

CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk

Xabier Garcia-Albeniz, Anja Rudolph, Carolyn Hutter, Emily White, Yi Lin, Stephanie A Rosse, Jane C Figueiredo, Tabitha A Harrison, Shuo Jiao, Hermann Brenner, Graham Casey, Thomas J Hudson, Mark Thornquist, Loic Le Marchand, John Potter, Martha L Slattery, Brent Zanke, John A Baron, Bette J Caan, Stephen J Chanock, Sonja I Berndt, Deanna Stelling, Charles S Fuchs, Michael Hoffmeister, Katja Butterbach, Mengmeng Du, W James Gauderman, Marc J Gunter, Mathieu Lemire, Shuji Ogino, Jennifer Lin, Richard B Hayes, Robert W Haile, Robert E Schoen, Greg S Warnick, Mark A Jenkins, Stephen N Thibodeau, Fredrick R Schumacher, Noralane M Lindor, Laurence N Kolonel, John L Hopper, Jian Gong, Daniela Seminara, Bethann M Pflugeisen, Cornelia M Ulrich, Conghui Qu, David Duggan, Michelle Cotterchio, Peter T Campbell, Christopher S Carlson, Polly A Newcomb, Edward Giovannucci, Li Hsu, Andrew T Chan, Ulrike Peters and Jenny Chang-Claude

Br J Cancer 2016 114: 221-229; advance online publication, January 14, 2016; 10.1038/bjc.2015.443

Abstract | Full Text

Hypermethylation of genes in testicular embryonal carcinomas

Hoi-Hung Cheung, Yanzhou Yang, Tin-Lap Lee, Owen Rennert and Wai-Yee Chan

Br J Cancer 2016 114: 230-236; advance online publication, December 1, 2015; 10.1038/bjc.2015.408

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: